Epstein-Barr Virus-specific Serum Immunoglobulin A As an Acute-phase Antibody in Infectious Mononucleosis

Overview

Journal J Clin Microbiol

Specialty Microbiology

Date 1979 Jul 1

PMID 227922

Citations 12

Authors

J Nikoskelainen

E U Neel

D A Stevens

Affiliations

Soon will be listed here.

Abstract

Immunoglobulin A (IgA) antibodies to Epstein-Barr virus viral capsid antigen were assayed serially in 19 patients with infectious mononucleosis and in 38 controls. Seventy-four percent of infectious mononucleosis patients demonstrated IgA antibody, whereas this was found in 13% of controls. This antibody appeared early in infectious mononucleosis and was virtually gone 10 weeks after onset. Comparison of IgA antibody kinetics was made with IgG and IgM antibodies to viral capsid antigen, heterophile antibody, and antibody to Epstein-Barr virus early antigen and nuclear antigen. Failure to demonstrate IgA antibody was associated with severe illness, prolonged illness, delay in IgG and anti-Epstein-Barr virus nuclear antigen antibody, and low or absent heterophile and anti-early antigen antibody. Assay of IgA antibody to viral capsid antigen is a potentially useful adjunct in the serodiagnosis of infectious mononucleosis or recent Epstein-Barr virus infection, as are the other antibodies tested, but in this study IgM viral capsid antigen antibody was the only acute-phase antibody present in all patients.

Citing Articles

Research landmarks on the 60th anniversary of Epstein-Barr virus.

Zhong L, Xie C, Zhang L, Yang Y, Liu Y, Zhao G Sci China Life Sci. 2024; 68(2):354-380.

PMID: 39505801 DOI: 10.1007/s11427-024-2766-0.

Serological diagnosis of Epstein-Barr virus infection: Problems and solutions.

De Paschale M, Clerici P World J Virol. 2013; 1(1):31-43.

PMID: 24175209 PMC: 3782265. DOI: 10.5501/wjv.v1.i1.31.

Prognostic factors of Chinese patients with T/NK-cell lymphoma: a single institution study of 170 patients.

Xu P, Wang Y, Shen Y, Wang L, Shen Z, Zhao W Med Oncol. 2011; 29(3):2176-82.

PMID: 21710236 DOI: 10.1007/s12032-011-0011-0.

Studies on the epidemiology of child infections in the Bari area (south Italy). VII. Epidemiology of Epstein-Barr virus infections.

LEOGRANDE G, Jirillo E Eur J Epidemiol. 1993; 9(4):368-72.

PMID: 8243590 DOI: 10.1007/BF00157392.

Enzyme-linked immunosorbent assay (ELISA) for detection of specific IgA antibodies to mumps virus.

Halevy B, Sarov I J Clin Pathol. 1982; 35(10):1129-33.

PMID: 7130422 PMC: 497896. DOI: 10.1136/jcp.35.10.1129.

References

Nikoskelainen J, Ablashi D, Isenberg R, Neel E, Miller R, Stevens D . Cellular immunity in infectious mononucleosis. II. Specific reactivity to Epstein-Barr Virus antigens and correlation with clinical and hematologic parameters. J Immunol. 1978; 121(4):1239-44. View

Papaevangelou G, Roumeliotou A, Alexiou D, Politou E, Papadatos C . Diagnostic value of IgG and IgM antibodies to capsid antigen of Epstein-Barr virus in infectious mononucleosis. J Infect Dis. 1977; 136(3):428-31. DOI: 10.1093/infdis/136.3.428. View

Ho H, Ng M, Kwan H, Chau J . Epstein-Barr-virus-specific IgA and IgG serum antibodies in nasopharyngeal carcinoma. Br J Cancer. 1976; 34(6):655-60. PMC: 2025221. DOI: 10.1038/bjc.1976.228. View

Schmitz H, Scherer M . IgM antibodies to Epstein-Barr virus in infectious mononucleosis. Arch Gesamte Virusforsch. 1972; 37(4):332-9. DOI: 10.1007/BF01241456. View

Nikoskelainen J, Leikola J, KLEMOLA E . IgM antibodies specific for Epstein-Barr virus in infectious mononucleosis without heterophil antibodies. Br Med J. 1974; 4(5936):72-5. PMC: 1612132. DOI: 10.1136/bmj.4.5936.72. View

Henie G, Henle W, Horwitz C . Antibodies to Epstein-Barr virus-associated nuclear antigen in infectious mononucleosis. J Infect Dis. 1974; 130(3):231-9. DOI: 10.1093/infdis/130.3.231. View

Edwards J, McSwiggan D . Studies on the diagnostic value of an immunofluorescence test for EB virus-specific IgM. J Clin Pathol. 1974; 27(8):647-51. PMC: 475421. DOI: 10.1136/jcp.27.8.647. View

Henle W, Henle G, Niederman J, KLEMOLA E, HALTIA K . Antibodies to early antigens induced by Epstein-Barr virus in infectious mononucleosis. J Infect Dis. 1971; 124(1):58-67. DOI: 10.1093/infdis/124.1.58. View

Schmitz H, Haas R . Determination of different cytomegalovirus immunoglobulins (IgG, IgA, IgM) by immunofluorescence. Arch Gesamte Virusforsch. 1972; 37(1):131-40. DOI: 10.1007/BF01241158. View

10.

Henle G, Henle W . Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int J Cancer. 1976; 17(1):1-7. DOI: 10.1002/ijc.2910170102. View

11.

Al-Nakib W, Best J, Banatvala J . Rubella-specific serum and nasopharygeal immunoglobulin responses following naturally acquired and vaccine-induced infection. Prolonged persistence of virus-specific IgM. Lancet. 1975; 1(7900):182-5. DOI: 10.1016/s0140-6736(75)91356-2. View

12.

Nikoskelainen J, Hanninen P . Antibody response to Epstein-Barr virus in infectious mononucleosis. Infect Immun. 1975; 11(1):42-51. PMC: 415022. DOI: 10.1128/iai.11.1.42-51.1975. View

13.

Evans A, Niederman J, Cenabre L, West B, Richards V . A prospective evaluation of heterophile and Epstein-Barr virus-specific IgM antibody tests in clinical and subclinical infectious mononucleosis: Specificity and sensitivity of the tests and persistence of antibody. J Infect Dis. 1975; 132(5):546-54. DOI: 10.1093/infdis/132.5.546. View

14.

HORNSLETH A, LEERHOY J, Grauballe P, Spanggaard H . Persistence of rubellavirus-specific immunoglobulin M and immunoglobulin A antibodies: investigation of successive serum samples with lowered immunoglobulin G concentration. Infect Immun. 1975; 11(4):804-8. PMC: 415138. DOI: 10.1128/iai.11.4.804-808.1975. View